NDC 68180-472 – Amlodipine Besylate and Benazepril Hydrochloride

Amlodipine Besylate 10 mg/1; Benazepril Hydrochloride 20 mg/1 · Capsule · Oral

Human Prescription Drug 1 recall

Product NDC68180-472

Product details

Brand name
Amlodipine Besylate and Benazepril Hydrochloride
Generic name
Amlodipine Besylate and Benazepril Hydrochloride
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA078466
Marketed since
August 1, 2018
Listing expires
December 31, 2026
Pharmacologic class
Angiotensin Converting Enzyme Inhibitor; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker

Active ingredients

Uses, dosage, side effects and warnings for Amlodipine Besylate and Benazepril Hydrochloride →

Package NDC codes (1)

Package NDCDescriptionSince
68180-472-01100 CAPSULE in 1 BOTTLE (68180-472-01)Aug 1, 2018

Recalls mentioning this NDC

Other Amlodipine Besylate and Benazepril Hydrochloride products